292 T. Kisnanto et al.: Radioprotection 2025, 60( 3), 285 – 292
Widjaja L, Werner RA, Krischke E, Christiansen H, Bengel FM, Bogdanova N, Derlin T. 2022. Individual radiosensitivity reflected by g-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy. Eur J Nucl Med Mol Imaging https:// doi. org / 10.1007 / s00259-022-05974-8
Willers H, Gheorghiu L, Liu Q, Efstathiou JA, Wirth LJ, Krause M, von Neubeck C. 2015. DNA damage response assessments in human tumor samples provide functional biomarkers of radiosensitivity. Semin Radiat Oncol 25: 237 – 250.
Cite this article as: Kisnanto T, Ramadhani D, Purwaningsih EH, Hakim RW, Basri IKH, Humani TS, Surniyantoro HNE, Syaifudin M, Purnami S, Suryandari DA. 2025. Gamma-H2AX as a biomarker to assess individual radiosensitivity for radiopharmaceutical therapy in cancer patients: a systematic review. Radioprotection 60( 3): 285 – 292. https:// doi. org / 10.1051 / radiopro / 2025004
Please help to maintain this journal in open access!
This journal is currently published in open access under the Subscribe to Open model( S2O). We are thankful to our subscribers and supporters for making it possible to publish this journal in open access in the current year, free of charge for authors and readers.
Check with your library that it subscribes to the journal, or consider making a personal donation to the S2O programme by contacting subscribers @ edpsciences. org.
More information, including a list of supporters and financial transparency reports, is available at https:// edpsciences. org / en / subscribe-to-open-s2o.